thevaccinereaction--2020-12-28--Patient in Georgia, Health Worker in New York Suffer Anaphylaxis After Getting Pfizer/BioNTech COVID

Patient in Georgia, Health Worker in New York Suffer Anaphylaxis After Getting Pfizer/BioNTech COVID-19 Vaccine

On Dec. 22 , 2020 , a patient at Decatur Morgan Hospital in Decatur , Alabama suffered a severe allergic reaction called anaphylaxis just minutes after receiving Pfizer/BioNTech ’ s experimental messenger RNA ( mRNA ) BNT162b2 vaccine for COVID-19.1 2 3 In a press release , the Alabama Department of Public Health ( ADPH ) stated the patient , who reportedly had a history of allergic reactions , was “ immediately treated with anaphylaxis protocol at Decatur Morgan Hospital where the vaccine was administered ” and was in stable condition and appeared to be recovering .
“ As required @ @ @ @ @ @ @ ) the adverse reaction has been documented and reported to the manufacturer , ” the ADPH confirmed.1 2 3 According to Karen Landers , MD of the ADPH , examples of anaphylaxis symptoms , which can be life-threatening , are tightness in the chest , coughing , wheezing , swelling of the lips and tightness in the throat.4 5 The National Vaccine Information Center ( NVIC ) notes that other symptoms of anaphylaxis may include hives , hypotension ( low blood pressure ) and shock.6 Multiple Cases of Anaphylaxis After COVID-19 Vaccination Reported @ @ @ @ @ @ @ reports of anaphylaxis in following administration of the first of two scheduled doses of the BNT162b2 vaccine during the past month and the U.S. Food and Drug Administration ( FDA ) is investigating these cases to determine the cause of the severe allergic reactions.7 8 9 10 Peter Marks , MD , PhD , director of the FDA ’ s Center for Biologics Evaluation and Research , has suggested the “ culprit ” behind the reactions could be a chemical ingredient called polyethylene glycol ( PEG ) —a polymer derived from petroleum used @ @ @ @ @ @ @ ) in both the BNT162b2 vaccine and Moderna ’ s COVID-19 vaccine known as mRNA-1273.7 11 12 On Dec. 23 , another case of anaphylaxis following vaccination with the BNT162b2 vaccine was reported in New York City .
The case involved a health care worker who suffered a “ significant allergic reaction.
” The individual , who works for the Mount Sinai Health System , was reported to be in stable condition and recovering.13 14 15 16